Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Ebeling Insider Profile
4 Followers
Thomas Ebeling, Director at Idenix Pharma, holds 0.00 shares in Idenix Pharma (Ticker: IDIX), holds 186.65K shares in Cullinan Management (Ticker: CGEM). Most recently, Thomas Ebeling ― shares of Idenix Pharma on ― for an estimated value of ―.
Thomas Ebeling Idenix Pharma (IDIX)Director
Idenix Pharma (IDIX)
Director
Not Ranked
Thomas Ebeling has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Thomas Ebeling holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thomas Ebeling
Thomas Ebeling's Trading History
Idenix Pharma
―
―
―
―
Cullinan Management
Jun 11, 2024
Director
Uninformative Buy
239.85K
$3.26M
List of latest transactions for each holding click on a transaction to see Thomas Ebeling's performance on stock
You May Also Like
Thomas Ebeling insider profile FAQ
What is the percentage of profitable transactions made by Thomas Ebeling?
The percentage of profitable transactions made by Thomas Ebeling is ―.
What is the average return per transaction made by Thomas Ebeling?
The average return per transaction made by Thomas Ebeling is ―.
What stocks does Thomas Ebeling hold?
Thomas Ebeling holds: IDIX, CGEM stocks.
What was Thomas Ebeling’s latest transaction?
Thomas Ebeling latest transaction was an Uninformative Buy of ―.
What was Thomas Ebeling's most profitable transaction?
Thomas Ebeling’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thomas Ebeling's role in Idenix Pharma?
Thomas Ebeling's role in Idenix Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.